Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'atherothrombosis' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stehouwer, CDA
      Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: Insights from studies of vascular structure and function

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    2. Leys, D
      Atherothrombosis: A major health burden

      CEREBROVASCULAR DISEASES
    3. Bogousslavsky, J
      Benefit of ADP receptor antagonists in atherothrombotic patients: New evidence

      CEREBROVASCULAR DISEASES
    4. Becker, RC
      Anticoagulation and the heart

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    5. Desai, A; Lankford, HA; Warren, JS
      Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: Implications for atherogenesis

      INFLAMMATION
    6. Auer, J; Berent, R; Maurer, E; Mayr, H; Weber, T; Eber, B
      Acute coronary syndromes - An update. Part I: Pathogenesis and drug therapy

      HERZ
    7. Serradell, M; Diaz-Ricart, M; Cases, A; Zurbano, MJ; Aznar-Salatti, J; Lopez-Pedre, J; Ordinas, A; Escolar, G
      Uremic medium disturbs the hemostatic balance of cultured human endothelial cells

      THROMBOSIS AND HAEMOSTASIS
    8. Hoffmeister, HM
      Atherothrombosis and inflammation

      ZEITSCHRIFT FUR KARDIOLOGIE
    9. Buemi, M; Marino, D; Di Pasquale, G; Floccari, F; Ruello, A; Aloisi, C; Corica, F; Senatore, M; Romeo, A; Frisina, N
      Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid

      THROMBOSIS RESEARCH
    10. Puddu, P; Puddu, GM; Muscari, A
      Current thinking in statin therapy

      ACTA CARDIOLOGICA
    11. Ganne, F; Vasse, M; Beaudeux, JL; Peynet, J; Francois, A; Mishal, Z; Chartier, A; Tobelem, G; Vannier, JP; Soria, J; Soria, C
      Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes -A possible protective mechanism against atherothrombosis

      THROMBOSIS AND HAEMOSTASIS
    12. Fournier, A; Mazouz, H; Pruna, A; Oprisiu, R; Albu, AT; Achard, JM; Fernandez, L
      Stroke prevention and antihypertensive treatment: may angiotensin receptortype I antagonist (AT1RA) be more protective than angiotensin-converting enzyme inhibitor (ACEI)?

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    13. Ikeda, H; Takajo, Y; Murohara, T; Ichiki, K; Adachi, H; Haramaki, N; Katoh, A; Imaizumi, T
      Platelet-derived nitric oxide and coronary risk factors

      HYPERTENSION
    14. van Guldener, C; Stehouwer, CDA
      Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    15. Milionis, HJ; Winder, AF; Mikhailidis, DP
      Lipoprotein (a) and stroke

      JOURNAL OF CLINICAL PATHOLOGY
    16. Kistler, JP; Furie, KL
      Patent foremen ovale diameter and embolic stroke: A part of the puzzle?

      AMERICAN JOURNAL OF MEDICINE
    17. Guillot, F
      Atherothrombosis as a marker for disseminated atherosclerosis and a predictor of further ischaemic events - A review

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    18. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    19. Kiechl, S; Willeit, J
      The natural course of atherosclerosis - Part I: Incidence and progression

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    20. Petit, L; Lesnik, P; Dachet, C; Moreau, M; Chapman, MJ
      Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages - Relationship to tissue factor induction by cholesterol and oxidized LDL

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    21. Priollet, P
      Arteriopathy of the lower limbs: towards a global medical care

      REVUE DE MEDECINE INTERNE
    22. Guillot, F
      Atherothrombosis as a marker for disseminated atherosclerosis and a predictor of further ischaemic events - A review

      EUROPEAN HEART JOURNAL
    23. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL
    24. Mazoyer, E; Drouet, L; Soria, C; Fruchard, JC; Pellerin, A; Arcan, JC; Tobelem, G
      Risk factors and outcomes for atherothrombotic disease in French patients:The RIVAGE study

      THROMBOSIS RESEARCH
    25. Schror, K
      Antiintregrins - new antiplatelet agents for prevention and treatment of acute coronary syndrome

      WIENER KLINISCHE WOCHENSCHRIFT
    26. NEUMAN MP; NEUMAN FJ; NEUMAN J; ROCCELLA MC; MONTENERO Y; BRUETMAN JE; GONZALEZ C
      EFFECT OF BEZAFIBRATE ON LIPID-PEROXIDATION IN PATIENTS WITH HYPERTRIGLYCERIDEMIA

      Advances in therapy
    27. AMBROSI P; GARCON D; RIBERI A; HABIB G; BARLATIER A; KREITMANN B; ROLLAND PH; BOUVENOT G; LUCCIONI R; METRAS D
      ASSOCIATION OF MILD HYPERHOMOCYSTEINEMIA WITH CARDIAC GRAFT VASCULAR-DISEASE

      Atherosclerosis (Amsterdam)
    28. BASTARD JP; BRUCKERT E; GIRAL P; BEUCLER I; ANKRI A; HAINQUE B; TURPIN G
      PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS ARE RELATED TO GAMMA-GLUTAMYL-TRANSFERASE IN HYPERLIPIDEMIC WOMEN

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    29. VALLABHAJOSULA S; FUSTER V
      ATHEROSCLEROSIS - IMAGING TECHNIQUES AND THE EVOLVING ROLE OF NUCLEAR-MEDICINE

      The Journal of nuclear medicine
    30. SIMOPOULOS AP
      OMEGA-3-FATTY-ACIDS IN THE PREVENTION-MANAGEMENT OF CARDIOVASCULAR-DISEASE

      Canadian journal of physiology and pharmacology
    31. JUHANVAGUE I; ALESSI MC; VAGUE P
      THROMBOGENIC AND FIBRINOLYTIC FACTORS AND CARDIOVASCULAR RISK IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Annals of medicine
    32. PETERSEN LJ; RINGSDAL VS; LADEFOGED SD; BASLUND B; HANSEN PR
      ANTICARDIOLIPIN ANTIBODIES AND LIPOPROTEIN (A) LEVELS IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH DIALYSIS - ASSOCIATIONS WITH ATHEROTHROMBOTIC DISEASE

      International journal of artificial organs
    33. FALKENBERG M; TJARNSTROM J; ORTENWALL P; OLAUSSON M; RISBERG B
      LOCALIZATION OF FIBRINOLYTIC ACTIVATORS AND INHIBITORS IN NORMAL AND ATHEROSCLEROTIC VESSELS

      Thrombosis and haemostasis
    34. TSCHOEPE D
      ADHESION MOLECULES INFLUENCING ATHEROSCLEROSIS

      Diabetes research and clinical practice
    35. CARTER AM; MANSFIELD MW; STICKLAND MH; GRANT PJ
      BETA-FIBRINOGEN GENE -445-G A POLYMORPHISM AND FIBRINOGEN LEVELS - RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN SUBJECTS WITH NIDDM/

      Diabetes care
    36. BASTARD JP; BRUCKERT E; ROBERT JJ; ANKRI A; GRIMALDI A; JARDEL C; HAINQUE B
      ARE FREE FATTY-ACIDS RELATED TO PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN ANDROID OBESITY

      International journal of obesity
    37. MANNUCCI PM
      RECENT PROGRESS IN THE PATHOPHYSIOLOGY OF FIBRINOGEN

      European heart journal
    38. ORTH M; LULEY C; MAYER H; WIELAND H
      RESPONSIVENESS OF ATIII AND COAGULATION-FACTOR-V AND COAGULATION-FACTOR-VII TO A STANDARDIZED ORAL FAT LOAD

      Thrombosis research
    39. ORTH M; LULEY C; WIELAND H
      EFFECTS OF VLDL, CHYLOMICRONS, AND CHYLOMICRON REMNANTS ON PLATELET AGGREGABILITY

      Thrombosis research
    40. SMITH FB; LEE AJ; RUMLEY A; FOWKES FGR; LOWE GDO
      TISSUE-PLASMINOGEN ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR AND RISK OF PERIPHERAL ARTERIAL-DISEASE

      Atherosclerosis
    41. BOSTOM AG; SHEMIN D; LAPANE KL; MILLER JW; SUTHERLAND P; NADEAU M; SEYOUM E; HARTMAN W; PRIOR R; WILSON PWF; SELHUB J
      HYPERHOMOCYSTEINEMIA AND TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN END-STAGE RENAL-DISEASE PATIENTS ON DIALYSIS - A CASE-CONTROL STUDY

      Atherosclerosis
    42. SCANU AM; EDELSTEIN C
      KRINGLE-DEPENDENT STRUCTURAL AND FUNCTIONAL POLYMORPHISM OF APOLIPOPROTEIN

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    43. ERNST E
      FIBRINOGEN - AN IMPORTANT RISK FACTOR FOR ATHEROTHROMBOTIC DISEASES

      Annals of medicine
    44. RACCAH D; LASSMANNVAGUE V; ALESSI MC; JUHANVAGUE I; VAGUE P
      INTRAPERITONEAL INSULIN ADMINISTRATION DOES NOT MODIFY PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN IDDM PATIENTS

      Diabetes care
    45. SMITH HA; THOMPSONDOBKIN J; YONAS H; FLINT E
      CORRELATION OF XENON-ENHANCED COMPUTED TOMOGRAPHY-DEFINED CEREBRAL BLOOD-FLOW REACTIVITY AND COLLATERAL FLOW PATTERNS

      Stroke
    46. CORTELLARO M; COFRANCESCO E; BOSCHETTI C; MUSSONI L; DONATI MB; CARDILLO M; CATALANO M; GABRIELLI L; LOMBARDI B; SPECCHIA G; TAVAZZI L; TREMOLI E; POZZOLI E; TURRI M; CORTELLARO M; COFRANCESCO E; BOSCHETTI C; CARDILLO M; TORRI M; RAINISIO M; GENTILE G; MOREO G; BIANCHI O; LEONARDI P; COLOMBI M; CATALANO M; GALIMBERTI P; RUSSO U; CRESSOTTI A; CARZANIGA G; NOBILI S; NINNO D; DONATI MB; IACOVIELLO L; DEGAETANO G; GABRIELLI L; MARTELLI E; CORSI G; LORENZI G; LOMBARDI B; CARRIERO MR; COLOMBO R; SPECCHIA G; CIOFFI P; SCIRE A; TAVAZZI L; GIANNUZZI P; CORRA U; TEMPORELLI L; MORA F; PICCO D; MORTARA A; ZECCA A; POGGI G; GIBELLINI R; MUSSONI L; TREMOLI E; GIANFRANCESCHI G; COLOMBO A; POZZOLI E; DEAMBROGGI L; DELLAVOLPE A
      INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY

      Arteriosclerosis and thrombosis
    47. FOSSATI P
      HYPERCHOLESTEROLEMIA - CONSENSUS AND CONT ROVERSIES ON CHOLESTEROL-LOWERING - WHAT ABOUT IT IN 1993

      Annales d'Endocrinologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 06:55:09